Skip to main content
TipRanks
Go Ultimate75% OFF

Telesis Bio (TBIO) Ratios

140 Followers

Telesis Bio Ratios

TBIO's free cash flow for Q3 2024 was $-7.01M. For the 2024 fiscal year, TBIO's free cash flow was decreased by $-55.00K and operating cash flow was $-6.96M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 23Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio3.714.089.573.0518.25
Quick Ratio3.223.929.332.9517.84
Cash Ratio0.192.258.512.3916.92
Solvency Ratio-1.07-1.31-1.47-0.32-0.16
Operating Cash Flow Ratio-4.24-2.87-3.77-2.73-3.71
Short-Term Operating Cash Flow Coverage0.000.00-60.86-11.54-12.06
Net Current Asset Value$ -10.52M$ 20.30M$ 67.71M$ -35.14M$ -14.83M
Leverage Ratios
Debt-to-Assets Ratio0.490.260.150.310.12
Debt-to-Equity Ratio1.160.460.19-0.33-0.64
Debt-to-Capital Ratio0.540.320.16-0.49-1.74
Long-Term Debt-to-Capital Ratio0.150.300.13-0.15-1.48
Financial Leverage Ratio2.381.751.28-1.06-5.17
Debt Service Coverage Ratio-13.05-22.32-18.26-7.84-2.95
Interest Coverage Ratio-14.99-23.78-25.84-23.71-4.68
Debt to Market Cap0.020.030.000.000.00
Interest Debt Per Share1.250.790.640.310.15
Net Debt to EBITDA-0.810.211.820.324.09
Profitability Margins
Gross Profit Margin61.62%56.84%38.93%55.12%-84.99%
EBIT Margin-162.11%-169.46%-340.26%-263.31%-141.77%
EBITDA Margin-147.20%-158.98%-326.01%-241.15%-123.93%
Operating Profit Margin-169.18%-169.44%-320.33%-248.80%-145.18%
Pretax Profit Margin-173.40%-176.59%-352.66%-273.80%-172.78%
Net Profit Margin-173.49%-176.68%-352.78%-273.87%-172.78%
Continuous Operations Profit Margin-173.49%-176.68%-352.78%-273.87%-172.78%
Net Income Per EBT100.05%100.05%100.04%100.03%100.00%
EBT Per EBIT102.49%104.22%110.09%110.05%119.01%
Return on Assets (ROA)-67.78%-59.57%-33.51%-67.04%-21.42%
Return on Equity (ROE)-161.57%-104.09%-42.91%70.74%110.65%
Return on Capital Employed (ROCE)-74.79%-68.50%-33.21%-77.04%-18.83%
Return on Invested Capital (ROIC)-72.66%-67.86%-32.64%-70.06%-18.51%
Return on Tangible Assets-72.81%-75.04%-39.14%-85.59%-25.62%
Earnings Yield-22.21%-7.62%-0.68%-0.19%-0.06%
Efficiency Ratios
Receivables Turnover4.604.693.012.903.22
Payables Turnover3.229.142.702.4814.48
Inventory Turnover2.625.382.854.9112.48
Fixed Asset Turnover0.803.221.921.745.41
Asset Turnover0.390.340.090.240.12
Working Capital Turnover Ratio0.860.440.230.320.06
Cash Conversion Cycle105.03105.74114.0552.80117.36
Days of Sales Outstanding79.4177.84121.14125.77113.34
Days of Inventory Outstanding139.1367.82128.1674.3429.24
Days of Payables Outstanding113.5239.92135.25147.3125.21
Operating Cycle218.55145.66249.30200.11142.57
Cash Flow Ratios
Operating Cash Flow Per Share-1.16-1.31-1.25-0.53-0.16
Free Cash Flow Per Share-1.22-1.47-1.31-0.53-0.16
Dividend Paid and CapEx Coverage Ratio-17.51-8.66-19.79-75.40-80.89
Capital Expenditure Coverage Ratio-17.51-8.66-19.79-75.40-80.89
Operating Cash Flow Coverage Ratio-1.01-1.81-2.12-1.85-1.34
Operating Cash Flow to Sales Ratio-1.26-1.41-3.32-2.34-1.33
Free Cash Flow Yield-17.05%-6.79%-0.68%-0.16%-0.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-4.50-13.13-146.30-540.44-1634.84
Price-to-Sales (P/S) Ratio7.8123.20516.121480.112824.66
Price-to-Book (P/B) Ratio7.2813.6762.78-382.31-1808.94
Price-to-Free Cash Flow (P/FCF) Ratio-5.86-14.74-147.84-624.53-2098.08
Price-to-Operating Cash Flow Ratio-6.20-16.44-155.31-632.81-2124.02
Price-to-Earnings Growth (PEG) Ratio1.24-0.55-1.28-2.5718.02
Enterprise Value Multiple-6.12-14.38-156.50-613.45-2275.08
Enterprise Value247.71M627.42M5.63B9.73B13.55B
EV to EBITDA-6.12-14.38-156.50-613.45-2275.08
EV to Sales9.0022.87510.191479.332819.59
EV to Free Cash Flow-6.76-14.53-146.14-624.20-2094.31
EV to Operating Cash Flow-7.15-16.21-153.52-632.48-2120.20
Tangible Book Value Per Share0.821.012.53-1.07-0.34
Shareholders’ Equity Per Share0.991.583.10-0.87-0.18
Tax and Other Ratios
Effective Tax Rate-0.00-0.00-0.00-0.000.00
Revenue Per Share0.920.930.380.220.12
Net Income Per Share-1.59-1.65-1.33-0.62-0.20
Tax Burden1.001.001.001.001.00
Interest Burden1.071.041.041.041.22
Research & Development to Revenue0.640.861.321.360.27
SG&A to Revenue0.770.811.290.630.98
Stock-Based Compensation to Revenue0.140.140.100.010.00
Income Quality0.730.800.940.850.77

Currency in USD